Steven Gillis, Director at VBI Vaccines Inc/BC (VBIV), bought 1,218,180 shares at $1.65 ($2.0M) on 2023-07-10, disclosed to the SEC on 2023-07-18.
Open-market purchase of $2.0M VBIV by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.65 | 609,090 | $1.0M | 50.0% |
| 2 | $1.65 | 609,090 | $1.0M | 50.0% |
| Total | $1.65 avg | 1,218,180 | $2.0M | 100% |
| Filing → |
| BOLD | BUY | 2024-04-04 | $3.2M | — | Filing → |
| CDAK | BUY | 2020-10-20 | $3.5M | — | Filing → |
| VBIV | BUY | 2019-09-23 | $5.0M | — | Filing → |